University of Edinburgh
Edinburgh, United Kingdom
NCT Number: NCT06223061
Cholecystectomy is amongst the most common surgical operations performed worldwide. Surgical candidates are treated for biliary pathologies, such as biliary colic, cholecystitis and gallstone pancreatitis. In patients who are deemed fit for surgery, cholecystectomy can be performed under three main settings: (1) emergency setting at index admission; (2) elective setting with no previous admissions; or (3) delayed setting with one or more previous gallbladder-related admissions.
The advent of laparoscopy fundamentally evolved biliary surgery and quickly became the "gold standard" approach. Recent multicentre collaborative studies have elucidated that the burden imposed on healthcare systems by laparoscopic cholecystectomies is primarily due to patient readmissions and complications arising from the operation, rather than perioperative mortality burden that was more commonly seen in open surgery. As a result, national and international societies have shifted their focus towards creating a culture of safety around this procedure, with the overarching goal of improving patient satisfaction and reducing hospital costs. The universal establishment of safe cholecystectomy is a complex process that relies not only on the operation itself, but also on various other factors such as promoting adequate training, improving hospital infrastructure, and enhancing perioperative patient care.
There remains a paucity of evidence around the variations of safe provision of laparoscopic surgery for gallbladder disease internationally, including low- and middle-income countries. To bridge this knowledge gap, the Global Evaluation of Cholecystectomy Knowledge and Outcomes (GECKO) study (GlobalSurg 4) will be an international collaborative effort, delivered by the GlobalSurg network, that will allow contemporaneous data collection on the quality of cholecystectomies using measures covering infrastructure, care processes and outcomes. It will be disseminated via contacts from the National Institute for Health and Care Research (NIHR) Global Surgery unit, leading emergency general surgeons and specialist organisations.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Edinburgh, United Kingdom
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30-days from surgery
Compliance to audit standards are defined as follows:
Time frame: 30-days of surgery
The quality will be assessed according to the rates of overall complications defined as the presence of Grade I to grade V Clavien-Dindo complication.
Time frame: 30-days of surgery
Occurence of bile duct injury within 30-days of surgery will be defined according to the Strasberg Classification
Time frame: 1-year from surgery
The rates of gallbladder cancer will be assessed at 1-year from the index surgery once the histology results are available.
University of Edinburgh
Other
Acronym: GECKO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06974045
Biliary Tract Diseases, Calculi
View Trial DetailsNCT03470584
Arthritis, Behavior
Chiayi City, Taiwan
View Trial DetailsNCT06969144
Biliary Tract Diseases, Calculi
Kathmandu, Nepal
View Trial DetailsNCT06953713
Biliary Tract Diseases, Calculi
Istanbul, Umraniye, Turkey (Türkiye)
View Trial Details